Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LENZ Therapeutics

盘后交易 01-12 19:42:08 EST

15.57

+0.70

+4.71%

盘后15.54

-0.03-0.19%

19:31 EST

最高15.79	最低14.43	成交量104.71万
今开14.94	昨收14.87	日振幅9.15%
总市值4.87亿	流通市值2.44亿	总股本3,129万
成交额1,596万	换手率6.67%	流通股本1,569万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":15.57,"timestamp":1768251600000,"preClose":14.87,"halted":0,"volume":1047057,"hourTrading":{"tag":"盘后","latestPrice":15.54,"preClose":15.57,"latestTime":"19:31 EST","volume":6814,"amount":106067.568936,"timestamp":1768264310879},"delay":0,"floatShares":15692500,"shares":31289969,"eps":-2.10871,"marketStatus":"盘后交易","change":0.7,"latestTime":"01-12 19:42:08 EST","open":14.94,"high":15.79,"low":14.43,"amount":15957346.573773,"amplitude":0.091459,"askPrice":15.88,"askSize":50,"bidPrice":14.71,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.10871,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768266000000},"marketStatusCode":4,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":14.87,"preHourTrading":{"tag":"盘前","latestPrice":14.85,"preClose":14.87,"latestTime":"09:25 EST","volume":2692,"amount":40713.105388,"timestamp":1768227903429},"postHourTrading":{"tag":"盘后","latestPrice":15.54,"preClose":15.57,"latestTime":"19:31 EST","volume":6814,"amount":106067.568936,"timestamp":1768264310879},"volumeRatio":0.842361,"impliedVol":1.0513,"impliedVolPercentile":0.8586},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2603521809","title":"Whitehawk Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603521809?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:31","pubTimestamp":1768239115,"startTime":"0","endTime":"0","summary":"北京时间2026年01月13日01时31分，Whitehawk Therapeutics, Inc.股票出现异动，股价快速跳水5.30%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cellectar Biosciences, Inc.、Beam Therapeutics Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为642.52%、132.36%、100.72%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Mindwalk Holdings Corp.，振幅分别为32.48%、31.29%、31.25%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113013155a7127730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","WHWK","LENZ"],"gpt_icon":0},{"id":"2602546441","title":"Gain Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602546441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602546441?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:37","pubTimestamp":1768228640,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时37分，Gain Therapeutics, Inc.股票出现波动，股价急速下跌5.19%。Gain Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.44%。Gain Therapeutics, Inc.公司简介：Gain Therapeutics Inc是一家生物技术公司，开发新型小分子疗法，用于治疗多个治疗领域的疾病，包括溶酶体储存疾病、中枢神经系统疾病、代谢疾病和肿瘤疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223720953c6cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223720953c6cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GANX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2603952570","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603952570?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228293,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时31分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下挫5.34%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Mereo Biopharma Group Plc、Day One Biopharmaceuticals, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为495.70%、103.78%、39.92%，振幅较大的相关个股有Zentalis Pharmaceuticals, Inc.、Novabay Pharmaceuticals, Inc.、Newcelx Ltd.，振幅分别为13.10%、10.95%、10.05%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2602830959","title":"Whitehawk Therapeutics, Inc.盘中异动 快速下挫5.90%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602830959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602830959?lang=zh_cn&edition=full","pubTime":"2026-01-10 02:21","pubTimestamp":1767982871,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日02时21分，Whitehawk Therapeutics, Inc.股票出现波动，股价大幅跳水5.90%。截至发稿，该股报2.55美元/股，成交量4.4599万股，换手率0.09%，振幅4.43%。Whitehawk Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Novabay Pharmaceuticals, Inc.、Cg Oncology, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为640.51%、78.12%、47.91%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为53.49%、38.11%、35.11%。Whitehawk Therapeutics, Inc.公司简介：Whitehawk Therapeutics Inc 是一种临床前阶段的肿瘤治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011002211197a157d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","WHWK","BK4139"],"gpt_icon":0},{"id":"2602630313","title":"Soleno Therapeutics, Inc.盘中异动 股价大跌5.09%报43.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602630313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602630313?lang=zh_cn&edition=full","pubTime":"2026-01-10 01:14","pubTimestamp":1767978845,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日01时14分，Soleno Therapeutics, Inc.股票出现异动，股价大幅跳水5.09%。Soleno Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Akoustis Technologies Inc涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为630.77%、72.24%、44.53%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Akoustis Technologies Inc、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为50.74%、36.28%、35.11%。Soleno Therapeutics, Inc.公司简介：Soleno Therapeutics Inc 是一家生物制药公司，开发用于治疗罕见病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110011405a7083391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110011405a7083391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SLNO","BK4007","BK4539"],"gpt_icon":0},{"id":"2602581423","title":"Jasper Therapeutics, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602581423?lang=zh_cn&edition=full","pubTime":"2026-01-09 23:51","pubTimestamp":1767973877,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日23时51分，Jasper Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。Jasper Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Zentalis Pharmaceuticals, Inc.涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为616.55%、54.89%、38.68%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Gri Bio, Inc.，振幅分别为38.05%、35.11%、30.25%。Jasper Therapeutics, Inc.公司简介：Jasper Therapeutics Inc 是一家临床阶段的生物技术公司，致力于通过造血干细胞疗法实现治愈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235117a4b1079b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109235117a4b1079b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JSPR","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2602584485","title":"Galectin Therapeutics Inc.盘中异动 早盘大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602584485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602584485?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:43","pubTimestamp":1767969822,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时43分，Galectin Therapeutics Inc.股票出现异动，股价大幅下挫5.00%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Zentalis Pharmaceuticals, Inc.涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为579.33%、32.42%、30.22%，振幅较大的相关个股有Atara Biotherapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Gri Bio, Inc.，振幅分别为27.69%、22.66%、18.80%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224342953c4c37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224342953c4c37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT","BK4007","BK4539"],"gpt_icon":0},{"id":"2602581559","title":"Bridgebio Oncology Therapeutics, Inc.盘中异动 股价大涨5.08%报13.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602581559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602581559?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:42","pubTimestamp":1767969756,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时42分，Bridgebio Oncology Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。截至发稿，该股报13.98美元/股，成交量3.2084万股，换手率0.04%，振幅3.98%。Bridgebio Oncology Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Bridgebio Oncology Therapeutics, Inc.公司简介：BridgeBio Oncology Therapeutics Inc，前身为BridgeBio Oncology Therapeutics，是一家临床阶段生物技术公司，旨在改变由两种经常发生突变的致癌基因RAS和PI3Ka驱动的癌症的患者生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109224236a4b0d664&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBOT","BK4007","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2602358508","title":"Vivos Therapeutics, Inc.盘中异动 急速拉升5.24%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602358508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602358508?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:32","pubTimestamp":1767969156,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时32分，Vivos Therapeutics, Inc.股票出现异动，股价快速上涨5.24%。Vivos Therapeutics, Inc.股票所在的医疗器械行业中，整体涨幅为0.38%。其相关个股中，Intelligent Bio Solutions Inc.、Autonomix Medical, Inc.、Quanterix Corporation涨幅较大，Envue Medical, Inc.、Autonomix Medical, Inc.、Intelligent Bio Solutions Inc.较为活跃，换手率分别为410.43%、303.14%、9.21%，振幅较大的相关个股有Quanterix Corporation、Beta Bionics, Inc.、Autonomix Medical, Inc.，振幅分别为9.83%、9.28%、7.97%。Vivos Therapeutics, Inc.公司简介：Vivos Therapeutics Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223237a707c697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109223237a707c697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","BK4139","VVOS","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2602843165","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602843165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602843165?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:30","pubTimestamp":1767969036,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时30分，Heron Therapeutics, Inc.股票出现异动，股价急速上涨5.24%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Uniqure N.V.涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为543.19%、29.03%、24.97%，振幅较大的相关个股有Allogene Therapeutics, Inc.、凯信远达、Artelo Biosciences, Inc.，振幅分别为7.25%、5.63%、5.63%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922303797a155b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922303797a155b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HRTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2602720983","title":"Kyverna Therapeutics, Inc.盘中异动 下午盘快速跳水5.06%报8.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602720983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602720983?lang=zh_cn&edition=full","pubTime":"2026-01-09 04:02","pubTimestamp":1767902551,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日04时02分，Kyverna Therapeutics, Inc.股票出现波动，股价大幅跳水5.06%。截至发稿，该股报8.26美元/股，成交量57.6845万股，换手率0.97%，振幅6.76%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.32%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为527.89%、127.75%、81.83%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为146.48%、59.43%、52.53%。Kyverna Therapeutics, Inc.公司简介：Kyverna Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109040232953c3d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109040232953c3d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KYTX","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2602085933","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘快速下跌5.19%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602085933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602085933?lang=zh_cn&edition=full","pubTime":"2026-01-09 03:55","pubTimestamp":1767902116,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日03时55分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下跌5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.25%。其相关个股中，Enliven Therapeutics, Inc.、Century Therapeutics, Inc.、Moonlake Immunotherapeutics涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为526.28%、127.45%、81.48%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Enliven Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为146.48%、59.43%、52.53%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109035516a70420d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109035516a70420d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2602323961","title":"Oruka Therapeutics, Inc.盘中异动 股价大跌5.03%报26.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602323961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602323961?lang=zh_cn&edition=full","pubTime":"2026-01-09 02:23","pubTimestamp":1767896601,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日02时23分，Oruka Therapeutics, Inc.股票出现波动，股价大幅下挫5.03%。Oruka Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Oruka Therapeutics, Inc.公司简介：Oruka Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发用于银屑病和其他炎症和免疫学（I&I）适应症的新型单克隆抗体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109022322a4ad0021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORKA","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"1172606657","title":"Lenz Therapeutics 公布2025年第四季度初步未经审计财务业绩及近期企业动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1172606657","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172606657?lang=zh_cn&edition=full","pubTime":"2026-01-08 06:09","pubTimestamp":1767823749,"startTime":"0","endTime":"0","summary":"Lenz Therapeutics 已发布其2025年第四季度的初步未经审计财务业绩，并同步更新了公司近期的业务进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2601833250","title":"Pelthos Therapeutics Inc.盘中异动 大幅上涨5.69%报29.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601833250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601833250?lang=zh_cn&edition=full","pubTime":"2026-01-08 03:43","pubTimestamp":1767815022,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日03时43分，Pelthos Therapeutics Inc.股票出现异动，股价快速上涨5.69%。截至发稿，该股报29.00美元/股，成交量6264股，换手率0.20%，振幅3.86%。Pelthos Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Pelthos Therapeutics Inc.公司简介：Pelthos Therapeutics Inc是一家临床阶段的生物技术公司，开发和商业化新型，非阿片类，非成瘾性治疗来减轻疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010803434297a13597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PTHS","LENZ","BK4539"],"gpt_icon":0},{"id":"2601336095","title":"Serina Therapeutics, Inc.盘中异动 快速拉升6.01%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601336095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601336095?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:31","pubTimestamp":1767807092,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日01时31分，Serina Therapeutics, Inc.股票出现波动，股价急速拉升6.01%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.09%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段的生物技术公司，开发一系列全资拥有的候选药物产品，用于治疗神经系统疾病和疼痛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010801313397a13534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010801313397a13534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","SER"],"gpt_icon":0},{"id":"2601035809","title":"美股异动 | MRT-8102一期试验数据积极 Monte Rosa Therapeutics(GLUE.US)盘前暴涨超42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601035809","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601035809?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:24","pubTimestamp":1767795857,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Monte Rosa Therapeutics盘前暴涨超42%，报22.76美元。消息面上，Monte Rosa Therapeutics正在进行的MRT-8102一期试验的中期数据显示，在心血管和心脏代谢疾病中C反应蛋白水平降低。在心血管疾病风险升高的受试者中，正处于研发阶段用于治疗NLRP3/IL-1/IL-6驱动的炎症性疾病的NEK7靶向分子胶降解剂MRT-8102显示出快速且持久的全身炎症减轻效果。经过四周的MRT-8102治疗后，C反应蛋白水平下降了85%，94%的研究参与者达到了低于2 mg/L的CRP值，这一阈值与降低的心血管疾病风险相关联。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4139","BK4230","BK4539","BK4007","MRT","GLUE"],"gpt_icon":0},{"id":"2601936805","title":"Vera Therapeutics的肾病药物获美国FDA优先审查","url":"https://stock-news.laohu8.com/highlight/detail?id=2601936805","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601936805?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:26","pubTimestamp":1767792390,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LENZ","BK4539","BK4588","BK4585","BK4139","BK4007","VERA"],"gpt_icon":0},{"id":"2601084320","title":"Stoke Therapeutics, Inc.盘中异动 大幅上涨5.02%报34.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601084320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601084320?lang=zh_cn&edition=full","pubTime":"2026-01-07 00:42","pubTimestamp":1767717730,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日00时42分，Stoke Therapeutics, Inc.股票出现波动，股价大幅上涨5.02%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Alumis Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2156.83%、1600.39%、233.97%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为294.74%、161.40%、71.00%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 是一家致力于利用 RNA 医药开发来恢复蛋白质表达的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107004211a4a42806&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107004211a4a42806&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","STOK","LENZ","BK4139"],"gpt_icon":0},{"id":"2601481542","title":"Lexeo Therapeutics, Inc.盘中异动 快速下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601481542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601481542?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:18","pubTimestamp":1767626298,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时18分，Lexeo Therapeutics, Inc.股票出现异动，股价快速跳水5.15%。Lexeo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.76%。Lexeo Therapeutics, Inc.公司简介：Lexeo Therapeutics Inc 是一家临床阶段的基因药物公司，致力于通过应用开创性科学从根本上改变疾病的治疗方式来改变医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010523181897a10e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010523181897a10e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","LXEO","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.graphitebio.com","stockEarnings":[{"period":"1week","weight":-0.0706},{"period":"1month","weight":-0.4062},{"period":"3month","weight":-0.6167},{"period":"6month","weight":-0.5713},{"period":"1year","weight":-0.4355},{"period":"ytd","weight":-0.0706}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立，并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司，利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法，以实现医学上最难以实现的目标之一：精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变，用正常基因替换整个致病基因，或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.14983},{"month":2,"riseRate":0.5,"avgChangeRate":0.077415},{"month":3,"riseRate":0.25,"avgChangeRate":-0.098838},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02248},{"month":5,"riseRate":0.25,"avgChangeRate":-0.134416},{"month":6,"riseRate":0.75,"avgChangeRate":0.05507},{"month":7,"riseRate":0.6,"avgChangeRate":0.05308},{"month":8,"riseRate":0.4,"avgChangeRate":0.016536},{"month":9,"riseRate":0.6,"avgChangeRate":0.026875},{"month":10,"riseRate":0.6,"avgChangeRate":-0.067546},{"month":11,"riseRate":0.6,"avgChangeRate":-0.005451},{"month":12,"riseRate":0.4,"avgChangeRate":-0.038411}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}